Hospice Care in Lewisville, TX
5 Hospice found. Showing 1 - 5
 Harris Hospice Inc Medicare Approved Location: 522 S Edmonds Lane Suite 103, Lewisville, Texas 75067 Phone: (972) 353-0800 |
Aspen Hospice Care Inc Medicare Approved Location: 314 W Main St Ste 700, Lewisville, Texas 75057 Phone: (972) 316-2035 |
Envoy Hospice North Llc Medicare Approved Location: 860 Hebron Parkway Suites 1203 & 1204, Lewisville, Texas 75057 Phone: (469) 470-2765 |
R2r Palliative And Hospice Care Medicare Approved Location: 860 Hebron Parkway Suite 203, Lewisville, Texas 75057 Phone: (972) 219-0020 |
Ally Palliative And Hospice Care Inc Medicare Approved Location: 625 Manco Apt 120, Lewisville, Texas 75067 Phone: (972) 480-4611 |
News Archive
LJI researcher awarded $1.6 million grant to study factors that trigger onset of type 1 diabetes
The American Diabetes Association has awarded La Jolla Institute researcher Stephanie Stanford, Ph.D., a $1.6 million grant to investigate the genetic and environmental factors that trigger the onset of type 1 diabetes.
Nasdaq issues Urologix a Staff Deficiency Letter
Urologix®, Inc. (NASDAQ:ULGX), received a Staff Deficiency Letter from The Nasdaq Stock Market on September 17, 2009, stating that the Company's stockholders' equity at June 30, 2009 was less than the $10 million minimum required for continued listing on The Nasdaq Global Market under Marketplace Rule 5450(b)(1)(A).
Connecticut passes law that bans minors from using indoor tanning devices
Connecticut has sent a strong message to young people that indoor tanning salons can be dangerous to their health by passing a law that bans minors under the age of 17 years old from using indoor tanning devices. The law is based on significant scientific evidence that links indoor tanning to increased risk of developing melanoma and other forms of skin cancer.
IOF presents eight young investigator awards to researchers across the world
Eight IOF Young Investigator Awards were presented by the International Osteoporosis Foundation (IOF) to young researchers from Australia, China, India and Japan, in recognition of their outstanding work. The awards, valued at 1,000 USD each, were awarded to the highest scored abstracts by researchers under the age of 40.
Kiadis Pharma commences enrollment in multinational ATIR study
Biopharmaceutical company Kiadis Pharma announces today that the first patients have been enrolled in its multinational registration clinical trial with ATIR(TM). The study is designed to show reduction in transplant related mortality (TRM) after one year following an allogeneic stem cell transplantation with a mismatched (haplo-identical) donor in blood cancer patients eligible for an allogeneic stem cell transplantation but without having a matched donor available.
› Verified 5 days ago